DJIA 16,424.85 162.29 1.00%
NASDAQ 4,086.23 52.06 1.29%
S&P 500 1,862.31 19.33 1.05%
market minute promo

98.22 2.11 (2.20%)

REAL-TIME: Last trade at

Extended Hours: $98.24 $0.02 (0.02%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

UTHR $98.22 2.20%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $97.29
Previous Close $96.11
Daily Range $95.95 - $98.90
52-Week Range $59.05 - $116.65
Market Cap $5.0B
P/E Ratio 29.30
Dividend (Yield) $0.00 (0.0%)
Volume 965,802
Average Daily Volume 901,946
Current FY EPS $6.93

Sector

Healthcare

Industry

Drugs

United Therapeutics Corp (UTHR) Description

A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases. Website: http://www.unither.com/

News & Commentary Rss Feed

Chelsea's Northera Gets Another Chance

A January advisory panel meeting and potential FDA approval in February could move the needle for this small biotech.

Healthcare Stocks Ending Near Session Lows; United Therapeutics Up 3% After Standpoint Touts Market-

Healthcare Stocks Ending Near Session Lows; United Therapeutics Up 3% After Standpoint Touts Market-Leading Position

Sector Update: Healthcare

Interesting UTHR Put And Call Options For November 22nd

United Therapeutics: 7 Different Insiders Have Sold Shares This Month

Supernus Pharmaceuticals: 2013 Revenues Exceed Analyst & Company Expectations; Maintaining Positive

Supernus Pharmaceuticals: 2013 Revenues Exceed Analyst & Company Expectations; Maintaining Positive Outlook

SUPN: 2013 Revenues Exceed Analyst & Company Expectations; Maintaining Positive Outlook

United Therapeutics: A Profitable Biotech With A Potentially Undervalued Pipeline

Catalysts That Could Push Top Biotech Stocks Even Higher

Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Lowest PEG Ratio

United Therapeutics Slips on Q4 Earnings Report - Analyst Blog

See More UTHR News...

UTHR's Top Competitors

UTHR $98.22 (2.20%)
Current stock: UTHR
AMGN $115.54 (0.47%)
Current stock: AMGN
GILD $69.28 (1.63%)
Current stock: GILD
BIIB $291.48 (2.10%)
Current stock: BIIB